Drug Type CAR-T |
Synonyms Anti-PD-L1/EphA2 CAR-T (VaxCell), VCB 1204, VCB1204 |
Target |
Action antagonists, inhibitors |
Mechanism EphA2 antagonists(Ephrin type-A receptor 2 antagonists), PDL1 inhibitors(Programmed death-ligand 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Preclinical | South Korea | 01 May 2025 | |
Solid tumor | Preclinical | South Korea | 01 Apr 2025 |